Tenet Healthcare (NYSE:THC) Issues Quarterly Earnings Results

Tenet Healthcare (NYSE:THC) announced its quarterly earnings data on Thursday. The company reported $6.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.26 by $1.86, FiscalAI reports. The firm had revenue of $6.04 billion for the quarter, compared to analysts’ expectations of $5.43 billion. Tenet Healthcare had a return on equity of 25.55% and a net margin of 7.94%.The company’s revenue for the quarter was up 6.8% compared to the same quarter last year. During the same period last year, the firm earned $4.02 earnings per share. Tenet Healthcare updated its FY 2026 guidance to 20.300-21.690 EPS.

Tenet Healthcare Stock Performance

Shares of Tenet Healthcare stock opened at $244.23 on Friday. Tenet Healthcare has a 12 month low of $146.60 and a 12 month high of $247.21. The company has a current ratio of 1.36, a quick ratio of 1.30 and a debt-to-equity ratio of 1.96. The business has a fifty day simple moving average of $184.43 and a two-hundred day simple moving average of $197.37. The firm has a market capitalization of $21.04 billion, a P/E ratio of 12.57, a P/E/G ratio of 1.62 and a beta of 1.27.

Analysts Set New Price Targets

Several research analysts recently commented on THC shares. Wells Fargo & Company lifted their target price on shares of Tenet Healthcare from $213.00 to $231.00 and gave the stock an “overweight” rating in a research note on Monday, July 13th. Barclays set a $271.00 price objective on shares of Tenet Healthcare in a research report on Friday. Guggenheim dropped their target price on shares of Tenet Healthcare from $252.00 to $242.00 and set a “buy” rating for the company in a report on Monday. Robert W. Baird cut their target price on Tenet Healthcare from $245.00 to $210.00 and set a “neutral” rating on the stock in a research note on Tuesday, May 5th. Finally, Morgan Stanley set a $254.00 price objective on Tenet Healthcare in a report on Friday, May 1st. Seventeen investment analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $246.47.

More Tenet Healthcare News

Here are the key news stories impacting Tenet Healthcare this week:

• Positive Sentiment: Tenet reported Q2 2026 earnings of $6.12 per share, well above expectations, and revenue of $5.63 billion, also ahead of Wall Street estimates. Management said stronger same-store revenue growth and expense control drove the beat. Article title
• Positive Sentiment: The company raised FY 2026 guidance, now calling for EPS of $20.30 to $21.69 versus prior expectations around $17.81, while revenue outlook of $21.9 billion to $22.5 billion remains broadly in line with consensus. Article title
• Positive Sentiment: Investors were already positioning for the report as the stock benefited from an improving credit profile, including Moody’s June upgrade, which signaled continued deleveraging and better financial flexibility. Article title
• Neutral Sentiment: Analysts have been generally constructive, with recent price targets and a consensus “Moderate Buy” stance providing additional support, but this is more of a backdrop than a fresh catalyst. Article title
• Negative Sentiment: Insider and congressional trading trends show more selling than buying over the past several months, which could temper enthusiasm, although this does not appear to be driving the stock’s move today. Article title

Insider Buying and Selling

In other news, Director J Robert Kerrey sold 5,638 shares of the stock in a transaction on Thursday, May 28th. The stock was sold at an average price of $174.52, for a total value of $983,943.76. Following the sale, the director directly owned 16,804 shares of the company’s stock, valued at approximately $2,932,634.08. This represents a 25.12% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Nadja West sold 3,000 shares of the stock in a transaction that occurred on Wednesday, May 27th. The shares were sold at an average price of $177.35, for a total transaction of $532,050.00. Following the sale, the director owned 24,805 shares in the company, valued at approximately $4,399,166.75. The trade was a 10.79% decrease in their position. The SEC filing for this sale provides additional information. 0.97% of the stock is owned by company insiders.

Institutional Trading of Tenet Healthcare

Hedge funds have recently bought and sold shares of the company. Triumph Capital Management bought a new stake in shares of Tenet Healthcare during the 3rd quarter valued at about $25,000. Canada Pension Plan Investment Board purchased a new stake in Tenet Healthcare during the second quarter valued at approximately $35,000. Meeder Asset Management Inc. boosted its stake in shares of Tenet Healthcare by 146.2% during the 4th quarter. Meeder Asset Management Inc. now owns 192 shares of the company’s stock worth $38,000 after acquiring an additional 114 shares during the last quarter. Geneos Wealth Management Inc. raised its holdings in Tenet Healthcare by 50.9% in the 2nd quarter. Geneos Wealth Management Inc. now owns 264 shares of the company’s stock worth $46,000 after purchasing an additional 89 shares during the period. Finally, Wilkerson Advisory Group LLC purchased a new position in Tenet Healthcare during the fourth quarter valued at $62,000. Hedge funds and other institutional investors own 95.44% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.